Sign in to follow this  
Followers 0

Pdufa V Announced!

3 posts in this topic

FDA has selected the following diseases to be addressed in FY 2013-2015:

Alpha-1 antitrypsin deficiency;

breast cancer;

chronic Chagas disease;

female sexual dysfunction;


hemophilia A, hemophilia B, von Willebrand disease, and other heritable bleeding disorders;


idiopathic pulmonary fibrosis;

irritable bowel syndrome, gastroparesis, and gastroesophageal reflux disease with persistent regurgitation symptoms on proton-pump inhibitors;

lung cancer;

myalgic encephalomyelitis/chronic fatigue syndrome;


neurological manifestations of inborn errors of metabolism;

Parkinson's disease and Huntington's disease;

pulmonary arterial hypertension; and

sickle cell disease.

Share this post

Link to post
Share on other sites

Well I hope something good comes out of it, but if the government is involved, I'm not really holding my breath, haha.

Share this post

Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
Sign in to follow this  
Followers 0